You are here
Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential
| Title: | Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential. |
 83 views 17 downloads |
|---|---|---|
| Name(s): |
Lohmueller, Jason J., author Sato, Shuji, author Popova, Lana, author Chu, Isabel M., author Tucker, Meghan A., author Barberena, Roberto, author Innocenti, Gregory M., author Cudic, Mare, author Ham, James D., author Cheung, Wan Cheung, author Polakiewicz, Roberto D., author Finn, Olivera J., author |
|
| Type of Resource: | text | |
| Genre: | Article | |
| Date Issued: | 2016-10-22 | |
| Summary: | MUC1 is a shared tumor antigen expressed on >80% of human cancers. We completed the first prophylactic cancer vaccine clinical trial based on a non-viral antigen, MUC1, in healthy individuals at-risk for colon cancer. This trial provided a unique source of potentially effective and safe immunotherapeutic drugs, fully-human antibodies affinity-matured in a healthy host to a tumor antigen. We purified, cloned, and characterized 13 IgGs specific for several tumor-associated MUC1 epitopes with a wide range of binding affinities. These antibodies bind hypoglycosylated MUC1 on human cancer cell lines and tumor tissues but show no reactivity against fully-glycosylated MUC1 on normal cells and tissues. We found that several antibodies activate complement-mediated cytotoxicity and that T cells carrying chimeric antigen receptors with the antibody variable regions kill MUC1+ target cells, express activation markers, and produce interferon gamma. Fully-human and tumor-specific, these antibodies are candidates for further testing and development as immunotherapeutic drugs. | |
| Identifier: | 10.1038/srep31740 (doi), http://www.nature.com/articles/srep31740 (uri), FAUIR000012 (IID) | |
| Persistent Link to This Record: | http://purl.flvc.org/fau/fd/FAUIR000012 | |
| Use and Reproduction: | publisher | |
| Host Institution: | FAU | |
| Is Part Of: |
Scientific Reports. 2045-2322 |
